Skip to content

α1-Antitrypsin

by Neomedica Doo Niš Serbia EUDAMED

Ref C1821ATR

EMDN W0102019002

Regulatory status

as of 24 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD NumberB-86060313275090 Basic UDI-DIDate4 Jun 2026RegisteredStatusActive

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Expiring (legacy directive)
  • Not covered

European Union — CE/IVDD Expiring (legacy directive)

Certificates: none listed in EUDAMED

Specification

EUDAMED · synced 24 Oct 2026

Model / Reference
C1821ATR
Primary DI / UDI-DI
86060313275090
Basic UDI-DI
B-86060313275090
EMDN Code
W0102019002 A1-antitrypsin (protease inhibitor)
Device Class
Class IVD General
Market of Registration
Northern Ireland

Manufacturer details

EUDAMED SRN
RS-MF-000021305
Authorised representative
Wellkang Ltd XI-AR-000001836

Other devices from Neomedica Doo Niš

See all devices from Neomedica Doo Niš →

Properties & raw data

Show properties, registry sources and raw records
  • Professional Testing
Other properties (9)
  • Sterile: No
  • Human Tissues: No
  • Animal Tissues: No
  • Microbial Substances: No
  • Reagent: No
  • Self Testing: No
  • Near-Patient Testing: No
  • Companion Diagnostics: No
  • Surgical Instrument: No

Sources (1)

  • EUDAMED 602bed65-3f26-4767-8a93-eb9582ea53ae 61 fields · synced 24 Oct 2026